Skip to content

Home-based Proprioceptive Neuromuscular Facilitation for Subjects With Type 2 Diabetes Mellitus

Effects of a Home-based Proprioceptive Neuromuscular Facilitation in Conjunction With Tendon Gliding Exercises on Sensorimotor Function in Upper Extremity of Subjects With Type 2 Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03248206
Enrollment
12
Registered
2017-08-14
Start date
2017-08-23
Completion date
2018-12-14
Last updated
2019-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Exercise

Brief summary

In this research work, the concept of strengthening technique of proprioceptive neuromuscular facilitation (PNF) incorporated with tendon gliding exercise (TGE) will be used to improve neuromuscular function of upper extremity of patients with diabetes mellitus. The first specific aim of the study is to examine the effects of home-based PNF exercise on the motor, sensation and functional performance parameters of upper extremity of the patients with diabetes mellitus. In addition, whether adding a tendon gliding exercise (TGE) to the home-based PNF exercises can provide better treatment effects for the patients with diabetes mellitus will also been investigated in this study. One of the hypothesis of this study is the prescribing home-based PNF exercise program has a positive treatment effect on neuromuscular function of the upper extremity of patients with diabetes mellitus. And,the other is home-based PNF in conjunction with TGE provides better benefits for neuromuscular function of the upper extremity of patients with diabetes mellitus.

Interventions

Providing a home-based exercise program supervised by therapists can be an acceptable strategy with the characteristics of convenience and inexpensiveness to promote neuromuscular and functional component for the patients with diabetes mellitus.

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Study participants will include clinically defined diabetic patients who are diagnosed based on the 1997 criteria of the American Diabetes Association. The inclusion criteria of the enrolled subjects are who suffered from neuropathy as diagnosed by abnormalities in either a nerve conduction study and / or quantitative sensory testing.

Exclusion criteria

* DM patients with (1) traumatic nerve injuries of the upper limbs, (2) trauma to the hand or congenital anomalies of the wrist and hand, (3) skin infections or disease, (4) known vascular complications of diabetes, such as stroke may have compromised the physical integrity of the patient, (5) grade 2 or higher arterial hypertension (\>160/100 mmHg) or (6) cognitive deficits

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline result of Semmes-Weinstein monofilament (SWM) test at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)determine the touch-pressure threshold of the hands
Change from baseline result of Nerve conduction study (NCS) at 12 weekspre-intervention (week 0) and follow-up evaluation (week 24)determine nerve condition through detection of the amplitude of the sensory and motor nerve action potential
Change from baseline result of pinch-holding-up activity test at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)sensorimotor control of a hand
Change from baseline result of Purdue pegboard test at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)determine fine fingertip dexterity
Change from baseline result of Minnesota Manual Dexterity Test at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)determine unilateral and bilateral gross motor coordination of upper extremity
Change from baseline result of Manual tactile test at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)determine active touching sensation

Secondary

MeasureTime frameDescription
Change from baseline result of Grasp and pinch power at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)Grip strength of the hands will be assessed with a Jamar dynamometer
Change from baseline result of peak torque of shoulder internal rotation assessing by Bi-planar isokinetic dynamometer (BID) at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)Peak torque (PT) of shoulder internal rotation (N⋅m) will be obtained
Change from baseline result of pinch power at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)Pinch power is measured with a pinch gauge
Change from baseline result of of shoulder flexion assessing by Micro FET hand-held dynamometer at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)Peak force of shoulder flexion (N) will be measured
Change from baseline result of shoulder internal rotation assessing by Micro FET hand-held dynamometer at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)Peak force of shoulder internal rotation (N) will be measured
Change from baseline result of shoulder external rotation assessing by Micro FET hand-held dynamometer at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)Peak force of shoulder external rotation (N) will be measured
Change from baseline result of peak torque of shoulder external rotation assessing by Bi-planar isokinetic dynamometer (BID) at 12 weekspre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)Peak torque of shoulder external rotation (N⋅m) will be obtained

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026